Summary.-Various procedures for immunoprotection in the A-SW mouse SEWA tumour system were compared. Four types of protector agents were used: polyoma virus, allogeneic S724 cells, A9/SEWA hybrid cells and xenogeneic STpy cells. Several injection schedules were also employed. On the whole, reasonable immunoprotection was obtained. The results, when allogeneic hybrid or xenogeneic cells were used, were comparable with those obtained for polyoma virus. This indicates that the T.A.T.A. of the SEWA tumour had been well conserved. When polyoma virus alone was used as the protector agent, injection 7 days before the tumour challenge, or iterative injection, afforded better protection than a single injection on the day of challenge.
THE AIM of this study was three-fold. Firstly, we wanted to compare the immunoprotective effect of allogeneic, hybrid and xenogeneic cells in the experimental system of A-SW mouse/polyoma induced tumour cell lines. We have previously shown that cells of C3H mice transformed in vitro by polyoma virus afforded a definite immunoprotection in AKR mice against a polyoma induced AKR tumour. The protection by these allogeneic cells was better than that afforded by polyoma virus (Favre and Meyer, 1972) .
We also wanted to observe the effect of the time of injection of the polyoma virus, used as the protector agent, on the anti-tumoral protection obtained. Previously, in a study of the kinetics of protection by polyoma virus in the AKR mouse/polyoma tumour system, we showed that the best immunoprotection was obtained when the virus was injected 5 days before the tumour challenge (Favre et al., 1971) .
Finally, we wanted to judge the effect of a more intense immunization by repeated injections of polyoma virus. In the polyoma virus-induced tumour/golden hamster system, repetition of the viral injections starting on the day of the tumour challenge (D-day) had led to enhancement (Favre, 1972) .
MATERIALS AND METHODS
Mice.-Two and one-half month old syngeneic A-SW mice, bred in our laboratories, were used.
Tumour cells.-A solid SEWA line (Sjogren, Hellstrom and Klein, 1961) , transplantable by subcutaneous, dorsal injection was used. This line was derived from a subcutaneous, ventral tumour obtained at the site of injection of ascitic SEWA cells.
Unlike the ascitic SEWA cells which only grow in vitro in suspension culture, these cells can be grown on glass. However, they still carry the neo-antigens characteristic of polyoma virus (Meyer, Berebbi and Klein, 1974) . Wiener et al. (1972) (Dulbecco, 1961; Lherisson-Straboni, 1969 ).
Allogeneic cells, S724.-The cells were obtained from a transplantable tumour, S724, derived from a primary tumour of the salivary glands in an AKR mouse (Bonneau, 1971) .
Hybrid cells, A9/SEEWA .-These hybrid cells were provided by Professor G. Klein (Harris et al., 1969) .
Xenogenic cells, STy. These cells were obtained from a transplantable tumour, STpy derived from a primary polyoma induced tumour in a golden hamster (Favre, 1972) .
One hundred and twenty mice were injected with 103 viable SEWA tumour cells in a 0 5 ml volume at Day D. They were then separated into 12 series of 10. The mice were given 0-5 ml subcutaneous, dorsal injections of either 106 P.F.U. polyoma virus (Py) or a million viable, allogeneic (S 724) or hybrid (A9/SEWA) or xenogenic (STpy) cells, or a combination of polyoma virus and the aforementioned viable cells. The exact immunization schedule is shown in the Table. The mice were examined clinically 3 times a week and autopsied at the end of the experiment or upon death.
The karyotype of the tumours was determined and found to be the same as the karyotype of the injected cells.
RESULTS

Turnour development
(a) Incidence of tumours.-As is shown in the Table, the treated groups developed less tumours than the control groups.
Each series of treated mice were compared statistically both with the control series and with all the other series of treated mice, using the direct method of comparison of proportion, a derivation of Fisher's method (Fisher and Yates, 1957) .
The probability (P) was calculated by the following formula:
where a = numerator ofthe two proportions compaired, n-(lenominator of the two proportions compared. (b) Time of appearance of the tumour. The significance of the times of appearance of the tumours was also assessed. For statistical purposes, the inverse of the time of appearance was used in the calculations. This allows the inclusion of the non-tumour bearing animals whose inverse times (1/xo) are zero (Meyer, Fondarai and Lherisson-Straboni, 1967; Meyer, Lherisson-Straboni and Fondarai, 1968) .
Simple analysis of variance, based on the comparison of variance (Snedecor's test) and subsequent calculation of the F ratios was performed to determine whether the differences observed between two or more series were significant. Values of 9500 or 990o were significant or highly significant.
The differences between each of the 9 test series and the control series were found to be significant or highly significant (see Table) confirming the results of section (a) control series were shown to be nonsignificant.
When the test series are compared one with the other, the difference is significant between series 1, having received a single injection at D -7 and series 4, having received repeated injections from Day D. The difference between series 3, having received repeated injections from D-7 and series 2, having received a single injection on the day of challenge, is highly significant.
The rest of the statistical analysis afforded no further information.
Frequency of metastases
Post-mortem examination confirmed the presence of a tumour in 28 animals.
Of these, 14 presented metastases of which 3 were multiple metastases. Counting these 3 mice, 8 cardiac, 6 pulmonary, 2 pleural, one renal and one para-renal metastases were observed.
The cardiac metastases were all myocardiac with neoplasic, intraventricular proliferation in either or both ventricles. Pleuro-pulmonary
Pararenal
The pulmonary or pleural metastases were composed of micronodules, which were occasionally confluent, particularly in the lung. The renal metastasis was massive with a pararenal invasion composed of a mass of extracapsular, neoplasic cells in the region of the adrenal gland. Practically all the organs, i.e. the liver, spleen, thymus, salivary glands, digestive tract and the aforementioned organs, with the exception of the nervous system and bones, were examined by autopsy. No organs other than those mentioned above were ever invaded.
DISCUSSION
The uniformity of the results for the test series leads us to believe that we can have confidence in the significant results obtained. This is true both when the number of tumour bearing animals per series was analysed and when the inverse of the time of appearance of the tumour was examined.
However, it is possible that by increasing the number of animals in each series a significant difference between the second and ninth series could be obtained. Ten animals per series were chosen since we considered this a large enough number for immunoprotection tests.
We could have also increased the number of cells used in the immunizing injection to obtain a better protection. However, we wanted our experimental conditions to correspond as closely as possible with those used in immunotherapy treatments in man. We therefore chose a million cells, the approximate number of cells used in treating residual human illness. We are, nevertheless, aware that the experimental situation is not exactly superimposable. For instance it is difficult to devise an injection schedule which corresponds with that used in man. We chose 3 injections a week without being certain that this was the optimal timing for immunization.
Further experiments are undoubtedly necessary to solve these problems. By varying the number of cells used and the timing of the injections, immunological responses ranging from protection to enhancement might be elicited.
We should also point out that there was a good conservation of the immunogenicity of the SEWA tumour derived from the ascitic tumour and no loss of T.A.T.A. for the solid tumour.
The results obtained for the first group show that the best protection is obtained when the immunizing injections of polyoma virus are given at D -7 rather than Day D. This confirms the results we have previously obtained in another experimental system (Favre et al., 1971 Allogeneic, hybrid and xenogeneic cells afforded a protection comparable with that obtained with polyoma virus. In the case of the hybrid and xenogeneic cells, better protection was obtained by associating these protector agents with polyoma virus. In the case of the allogeneic cells, however, association with the virus clearly diminished the protective effect. We find this result inexplicable. Apparently, it is not an enhancement since the animals showed fewer tumours than the control group and these tumours were slow to appear.
The frequency of metastatic localizations seemed as great in the immunized animals as in the controls, but only the latter presented tumours.
Metastases (Takasugi and Klein, 1970) .
